Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT00491192
Eligibility Criteria:
Inclusion Criteria:
* Patients with severe traumatic injury or subarachnoid hemorrhage in coma (GCS\<8), intubated, mechanically ventilated with intracranial pressure (ICP) and invasive arterial pressure monitoring
Exclusion Criteria:
* Know adverse reactions with NSAI
* Platelets count \< 20,000/dl
* Gastric or duodenal ulceration in active phase
* Hepatic insufficiency, cirrhosis or previous liver transplant
* Acute or chronic renal insufficiency
* Coronary insufficiency, acute myocardial infarct in the previous 6 month
* Barbiturate coma
* Patients in therapy with acetylsalicylic acid, lithium, digoxin, methotrexate and cyclosporin.
* Known or suspected pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT00491192
Study Brief:
Protocol Section:
NCT00491192